ABSTRACT Three groups of eight gilts weighing 20, 40, or 60 kg were fitted with indwelling venous catheters to determine daily integrated circulating levels (DICL, serum concentration above baseline x time) of insulin, growth hormone (GH), glucagon, glucose, urea, and nonesterified fatty acids (NEFA) in response to acute challenge with porcine pituitary GH (pGH). Pigs were fed a common diet containing 18% CP and 3.5 Mcal of DEkg between 0800 and 1200 (85% of ad libitum). Blood and urine were collected at 2-or 4-h intervals for 4 d. On d 2, 3, and 4, four pigs in each group were injected i.m. at 0800 with pGH ( . 1 mgikg) and four pigs (controls) were injected with buffer. In control pigs DICL of GH was 20.4, 14.1, and 10.2 ng pGH.h.mL-l in 20-, 40-, and 60-kg pigs, respectively. The DICL of GH in pGH-treated pigs was 4.2-, 7.0-, and 10.7-fold greater in 20-, 40-, and 60-kg pigs, respectively, than in controls. The DICL of insulin in control pigs was 7.9, 9.7, and 9.4 ngh.mL-l and was increased ( P < .001) in pGH-treated pigs by 118, 213, and 276% in 20-, 40-, and 60-kg pigs, respectively. Although serum levels of glucose were increased ( P < ,001) by pGH treatment, the acute elevation observed in 60-kg pigs was more consistent relative to 20-and 40-kg pigs. In contrast, the acute reduction in blood urea upon pGH injection was more apparent in 20-kg gilts. Urea excretion was also reduced ( P < .002) in pGH-treated compared with control gilts, whereas creatinine excretion was influenced by weight ( P < .001) and not by pGH treatment ( P < .74). Circulating levels of NEFA were influenced by pGH treatment, but only apparently in 60-kg pigs. Data suggest that administration of pGH alters amino acid metabolism in pigs 2 20 kg, but direct acute effects on lipid metabolism may be limited to larger pigs, which are exposed to a greater effective concentration of injected hormone relative to baseline control levels of circulating GH.
Introduction
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J. h i m . Sei. 1993 Sei. . 71397-905 al., 1988 Evock et al., 1988; Caperna et al., 1990) . Studies with pigs chronically treated with pGH have revealed changes in insulin sensitivity, glucose metabolism, and circulating urea nitrogen levels compared with controls Gopinath and Etherton, 1989b; Wray-Cahen et al., 1991; Dunshea et al., 1992b) . Previous studies that have attempted to address the acute responses to pGH administration have yielded conflicting results. Initially, it was demonstrated that acute responses (< 8 h ) to pGH treatment of barrows were minimal (Gopinath and Etherton, 1989a) . Recently, however, Dunshea et al. (1992a) used acutely treated barrows (71 kg) to demonstrate substantial effects of pGH on metabolite and hormone responsiveness within the first several hours of treatment. To date, studies on the effects of pGH administration on circulating patterns of hormones and metabolites have focused on pigs that exceeded 60 kg BW (Gopinath and Etherton, 1989a; Wray-Cahen et al., 1991; Dunshea et al., 1992a) . Moreover, growing evidence suggests that younger pigs do not readily respond to pGH treatment (Evock et al., 1988; Evans et al., 1991) . The purpose of the present investigation was to characterize, over several consecutive days, hormone and metabolite profiles of pGH-treated gilts. In addition, it was our intention to elucidate the effect of weight (or age) on acute responses to pGH challenge in a controlled environment and with specific feeding conditions.
Materials and Methods

Animals and Treatments.
A total of 24 crossbred gilts from the same farrowing group (Yorkshire x Landrace x Duroc) were included in the study. Three groups of eight gilts were used with target weights for the start of each trial to be 20, 40, or 60 kg BW. Before the start of the bleeding trial all gilts had ad libitum access to a corn-soybean meal-skim milk-based diet containing 18% CP and 3.5 Mcal of DE/kg (Campbell et al., 1988) . Water was also available ad libitum. When each group of gilts reached target weight, they were placed in metabolism crates to acclimate them to the new environment and to begin restricted feeding. Pigs were fed 85% of predicted ad libitum energy intake according to an ARC formula (ARC, 1981; megacalories of DEiday = .85 x 13.15 (1-e-.024 BW).
Pigs were fed at 0800 and allowed access to feed for 4 h. The crates (56 x 122 x 76 cm, w x 1 x h ) were constructed with stainless steel front and back panels and clear Plexiglas side panels. The floor consisted of a stainless steel urine collection system with a raised, vinyl-coated wire mesh situated above a stainlesssteel fecal collection screen. The top of each crate was completely open to allow adequate ventilation. Lowlevel fluorescent lighting was maintained throughout the night to facilitate blood and urine sampling. Four days after the pigs were placed in metabolism crates each gilt was fitted with an indwelling vena cava catheter as described by Brocht et al. (1989) . Catheterization of 20-and 40-kg pigs was accomplished with the aid of a mild sedative (acepromazine maleate, 20 to 30 mg; ketamine hydrochloride, 100 to 200 mg), whereas the 60-kg pigs were not sedated. On the following day ( d 1 ) blood samples were withdrawn and urine was collected in plastic jugs. Initial blood samples were taken at 0800 (before feeding, t = 0 ) and 2, 4, 6, 8, 12, 16 , and 20 h later. All pigs were allowed access to feed between 0800 and 1200. On the following day ( d 2), blood was collected at 0800 ( t = 24 h ) and pigs were then immediately fed. Blood samples were collected 2, 4, 6, 8, 12, 16 , and 20 h later. The same feeding and bleeding schedule was followed for the next 2 d. The trial was terminated at 0800 on d 5.
Immediately after the collection of blood and presentation of feed (at approximately 0801) on d 2, 3, ant1 4 (24, 48, and 72 h clock time), four gilts were inject J with excipient and four were injected with pGH (USDA-B 1 pituitary-derived pGH, 100 pgikg) prepared fresh in diluent (.05 M carbonate-bicarbonate buffer in .15 M NaCl, pH 9.5). All injections were carefully placed into the extensor muscle of the neck using a 21-guage, 3.8-cm needle. Each time blood was collected, urine volume was determined, and a 5-mL, aliquot was frozen for future analysis. Blood was allowed to clot for 30 min at room temperature and serum was collected by centrifugation. Serum was divided into several small vials so that each assay could be performed on a fresh, unthawed sample. The sample kept for glucagon determination was stored in the presence of aprotinin, a protease inhibitor (Sigma Chemical, St. Louis, MO).
AnaZyticaZ Techniques. Serum glucose was determined colorimetrically as previously described (Campbell et al., 1988) . Serum NEFA were determined colorimetrically (NEFA-C kit, WAKO Chemicals USA, Dallas, TX) ; background oxidase activity (presumably ceruloplasmin) was determined for each sample and subtracted out. Urea in serum and urine was determined colorimetrically by automated analysis (Technicon, method of Chaney and Marbach, 1962) . Urinary creatinine was also determined colorimetrically (method 555-A, Sigma).
The concentrations of pGH, insulin, and glucagon in serum were determined by RIA using polyclonal antisera prepared against porcine polypeptides as previously described (Allen and McMurtry, 1984; Campbell et al., 1988) . Pancreatic specific porcine glucagon antibody ( K 5563) and highly purified porcine glucagon used as standard were purchased from Novo Research (Wilton, CT) and [12511-glucagon tracer was purchased from Cambridge Medical Diagnostics (Billerica, MA). Daily integrated circulating levels (DICL) of hormones and metabolites were estimated by determining the area under the curve above background levels. This was accomplished by plotting the hormone or metabolite concentration at each time point for the 4-d period for each individual animal (Sigma Plot, Jandel Scientific, Corte Madera, CA). An average of the four lowest points during the 4 d was used as a baseline value, except for blood urea, for which a two-point baseline was established for each day. The area above the baseline for each response criterion of each individual animal was estimated using an integrating-scanning device (Sigma Scan, Jandel Scientific). For quantitative and comparative purposes, the average DICL values for the experimental period (d 2 to 4) were determined and the influence of weight and pGH treatment was evaluated for statistical significance by standard ANOVA procedures. 
Results
Initial and final weights of each group of pigs as well as feed intake data are given in Table 1 . These data are provided because hormone and metabolite patterns are influenced by quantity and timing of feed intake. During the 4-d period approximately 89% of all feed provided was consumed; however, it should be noted that by d 4 a significant drop in feed intake was noted, particularly in some heavier pGH-treated pigs. This may be due in part to the known reduction in feed intake associated with pGH treatment (Dunshea et al., 1992a) as well as to reduced physical activity of pigs maintained in metabolism crates.
Temporal patterns of circulating pGH in control and pGH-treated pigs are shown in Figure 1 . In control pigs, little fluctuation was observed in circulating levels of GH. Intramuscular injection of pGH at 0801 was associated with a rapid increase in circulating pGH levels, which returned to baseline levels by 12 h after injection in all pigs. In control pigs, DICL of GH was approximately twofold greater in 20-kg pigs than in 60-kg pigs; DICL of pGH in 40-kg pigs was intermediate ( Table 2 ). In contrast, treatment with the same dose of pGH (100 pgkg BW) resulted in a linear increase (associated with pig weight) in DICL of pGH of treated pigs. Thus, treatment with a constant dosage of pGH resulted in a 4.3-, 7.0-, and 10.7-fold increase in DICL of GH compared with controls in 20-, 40-, and 60-kg pigs, respectively.
Initiation of feeding in all pigs resulted in an immediate increase in circulating levels of insulin (Figure 2 ). In control pigs insulin levels returned to baseline levels between 8 and 12 h after feeding. The aPigs were restrictively fed 85% of the calculated voluntary intake using the following equation: Mcal of DEid = .85 x 13.15 (1 -e-.0204 bPigs were injected at approximately 0801 on d 2, 3, and 4 with either pGH or excipient immediately following feeding (24, 48, and 72 h). cPigs were weighed on d 0, before catheterization (initial wt) and again after completion of the experiment.
BW Feed was provided at 0800 and removed at 1200. b a l u e s represent means f SEM ( n = four pigs per group) of the daily integrated circulating levels (DICL) averaged over the three
Values represent means f SEM ( n = 4 pigs per group) of the daily integrated circulating levels (DICL) averaged for d 2 and 3.
experimental days (2, 3, and 4).
DICL of insulin remained relatively constant for control pigs of various weight classes. Treatment of pigs with pGH concomitant with feeding resulted in a rapid increase in insulin concentration that was significantly higher ( P < .001) than control levels. In addition, the rate of return to baseline was extended in pGH-treated pigs and was particularly evident in 60-kg pigs. There was an interaction ( P < .009) between weight of pigs and pGH treatment; in contrast to control pigs, as weight increased, the DICL of insulin also increased in response to pGH treatment (Table 2) . Compared with control pigs, DICL of insulin was 2.2-, 3.1-, and 3.8-fold higher in pGHtreated pigs at 20, 40, and 60 kg, respectively. Circulating concentrations of glucagon did not vary greatly among all pigs used in this study (data not shown); thus, DICL of glucagon was similar for most groups of pigs (Table 2 ) . However, there was an apparent weight-related increase in DICL of glucagon among pigs treated with pGH. This may be the result of a response to the specific elevated levels of insulin in heavier pGH-treated pigs, as discussed above.
Serum urea increased in response to feeding in control and pGH-treated pigs (Figure 3) . Daily integrated circulating levels of urea remained relatively constant for control pigs (Table 3) . In response to acute administration of pGH, concentration of urea was decreased in 20-kg gilts, but this was not observed until the 2nd or 3rd d of treatment in heavier pigs. Overall, pGH treatment was associated with a 52, 32, and 22% decrease ( P < .OO 1) in DICL of serum urea compared with appropriate controls at 20, 40, or 60 kg, respectively.
In control pigs, serum glucose tended to increase after feeding (Figure 4) . Forty-kilogram control pigs had higher levels of glucose than either 20-or 60-kg pigs. Treatment with pGH resulted in marginal glucose increases in 20-and 40-kg pigs, whereas 60-kg pigs demonstrated the greatest increases in serum glucose upon acute treatment with pGH.
In most pigs NEFA tended to be highest just before feeding at 0800 (Figure 5 ) . A specific increase in midday concentrations of NEFA attributable to pGH administration was only evident in 60-kg pigs, and possibly on d 4 for 40-kg pigs. Because of high variability among pigs and in the determination of DICL values for NEFA, significant age or pGH responsiveness was not observed (Table 3) .
Urinary excretion of urea and creatinine was determined for each of the experimental days (Table  4) . In all pigs, urea and creatinine excretion was increased as weight of the pigs was increased. Urinary excretion of urea was decreased by 37, 31, and 43% in 20-, 40-, and 60-kg pigs, respectively, in pGH-treated compared with control pigs. In contrast, urinary creatinine was not influenced by pGH treatment.
Discussion
The objective of the present investigation was to determine whether weight has any influence on the temporal patterns of hormones and metabolites that are altered as a result of acute pGH administration. In addition, because circulating levels of metabolites such as glucose and urea are directly influenced by feeding, it was our intention to feed the pigs one meal per day and directly compare the responses attributable to feeding to those animals that were fed and injected concomitantly with pGH. Although this design introduces some cyclicity into circulating hormone and metabolite patterns, it also eliminates a major source of variation that cannot be readily controlled for each pig (i.e., the exact timing and coordination of feed intake). Present data from control pigs indicated that circulating amounts of GH were approximately twice as high in 20-kg pigs as those in 60-kg pigs. Dubreuil and coworkers ( 19 8 7) measured circulating GH levels over a 5-h window and also demonstrated decreased levels of GH in aging barrows and gilts. Moreover, regulation of GH secretion as a function of age is likely to be a complex process that apparently involves altered sensitivity to stimulatory and inhibitory neuropeptides as well as to second messengers in pituitary cells (Parenti et al., 1991) . For example, Baker et al. (1956) observed that although the amount of GH activity in pituitaries increased with age, there is a specific decline relative to body size in the amount of available GH. It has also been demonstrated that hepatic GH receptors gradually increase with age (Breier et al., 1989) . Whether this phenomenon also occurs in other tissues has not been investigated. It has been shown by Althen and Gerrits (1976) that the half-life ( t 1/21 of circulating GH increased and the proportional rates of metabolic clearance and secretion decreased in mature pigs compared with immature pigs. Taken together, these data imply that although GH receptor concentration may increase (and total numbers increase as well due to tissue growth), coincident with a decrease in GH clearance rates, the actual amount of available GH decreases. Thus, at the tissue level, the pig is exposed to progressively lower amounts of GH throughout the aging process. This would support the idea that the levels of GH are suboptimal for maximal growth in pigs (Reeds, 1987) , even in animals that weigh 20 kg. Present data and results from recent studies (in which 29-kg, restrictively fed barrows responded to pGH administration during the 1st wk of treatment; Caperna, unpublished data) suggest that in young barrows ( < 30 kgj levels of GH may also be a primary constraint on growth. This lack of adequate GH as characterized by the ability of the normal pig to respond to exogenous hormone treatment (Reeds, 1987) is clearly one of the major constraints on protein deposition in rapidly growing pigs.
After injection of pGH at a dose of 100 pgkg BW, DICL of GH was 53% higher in 60-than in 20-kg pigs (with control levels subtracted out). If the dosage is calculated on a per kilogram of metabolic BW basis (MBW, weight.75) the amount given is 32% higher for 60-kg pigs than for 20-kg pigs (278 vs 211 pgkg MBW, respectively). The additional complement of circulating GH observed in larger pigs in response to pGH injection must also be related to the decrease in metabolic clearance rate in older pigs, as described by Althen and Gerrits (1976) . This difference in the circulating levels of pGH after i.m. administration may partially explain why pGH treatment seems to alter growth in larger pigs to a greater extent than in smaller pigs . Indeed, in studies in which low levels of pGH were administered to very young pigs it had been concluded that pGH does not influence growth (Evans et al., 1991) . However, it is difficult to assess directly the overall effects of pGH treatment in animals that have ad libitum access to feed because protein and lipid deposition are integrally tied to energy intake in control and pGH-treated pigs (Campbell et al., 1988) . The nature and definition of what constitutes a response to pGH treatment must also be considered.
In control pigs the concentration of insulin increased approximately 10-fold at 2 h after initiation of feeding and returned to baseline levels between 8 and 12 h. The concentration of insulin increased sharply in pGH-treated pigs and peaked at approximately 4 to 6 h after injection and feeding, regardless of age of the pig. However, the magnitude of the response was weight-dependent and increased with weight of the pig. This could in part be due to a concomitant increase in effective concentration of pGH associated with treatment of the larger pigs. Evock et al. (1988) demonstrated that insulin levels increased as the dose of pGH was elevated in chronically treated pigs. In the present study, there was a delay in the return to baseline levels that was particularly evident in 40-and 60-kg pigs. Dunshea et al. (1992a) reported a longer time before peak insulin concentration was observed, 12 to 16 h after acute administration of pGH. In that study, pigs were fed to appetite and insulin values did not return to control levels. Similar to present findings, insulin levels peaked at 6 h (Wray-Cahen et al., 1991) in meal-fed pigs (two meals per day) that were treated with pGH for 9 d. In that study, another insulin peak was observed after a second feeding (18 h after pGH treatment). Thus, it would seem that in both acute (present data) and chronic conditions (Wray-Cahen et al., 1991) , pGH alters insulin secretory patterns (or turnover) in response to input of dietary nutrients and not as a direct response to pGH injection. Moreover, in pigs fed once daily and treated with recombinant pGH for 35 d, baseline levels of insulin (samples collected before feeding) were similar to those of control pigs (Caperna et al., 1990) , whereas pigs with ad libitum access t o feed treated with pGH have chronically elevated levels of insulin (Dunshea et al., 1992a) .
Serum glucose was elevated by pGH treatment in a weight-dependent manner; as weight was increased, the relative increase in serum glucose became greater. The increase in serum glucose associated with pGH administration was quite variable but seemed to be most pronounced in 60-kg pigs. Thus, the chronically elevated levels of glucose in pGH-treated pigs are either associated with long-term treatment or are specific to larger pigs ( > 40 kg). It seems likely, therefore, that if one of the primary actions of GH on adipose tissue is to block insulin and insulin-like growth factor I-stimulated lipogenesis (Walton et al., 19871 , then the greatest effect on energy metabolism would be seen in pigs that have a higher rate of lipogenesis irrespective of the actual levels of insulin. This concept has been previously proposed and present data are in general agreement; however, the increased relative dosage of pGH associated with larger pigs must also be considered.
Consistent with available data (Wray-Cahen et al., 1991; Dunshea et al., 1992a1 , pGH administration was associated with a decline in circulating urea levels. In contrast to what we observed in glucose status, the acute response in amino acid metabolism as defined by a reduction in circulating levels of urea was most clearly observed in 20-kg gilts. Reduced circulating levels of urea were also confirmed by quantification of total daily urinary urea output. Thus, alterations in energy metabolism seem to be more highly influenced by pGH in larger pigs, whereas acute effects of pGH on amino acid metabolism seem to be more sensitive in smaller animals that have a higher relative rate of protein deposition. Whether this acute response to pGH in smaller pigs represents changes in visceral or carcass protein metabolism, or both, remains to be determined. In 20-kg control gilts urinary urea N excretion represented 15% of the N provided in feed, whereas in pGH-treated pigs urinary urea N represented only 7% of total N intake. In contrast, urinary urea N excretion represented 41 and 37% of the total N intake in 40-and 60-kg control pigs, respectively. In pGH-treated pigs urinary urea N represented 27 and 34% of total N intake of 40-and 60-kg pigs, respectively. This study confirms the observations of Dunshea et al. (1992a) that acute administration of pGH is associated with rapid changes in protein and energy metabolism. In addition, these data extend present knowledge and demonstrate that young pigs do respond to acute pGH administration. It is unclear why Gopinath and Etherton (1989a) did not observe acute effects of pGH; however, an acute response to pGH (insulin and glucose) may not be attained without the input of dietary nutrients. Pigs in that study were fasted during the treatment period. In addition, route of administration, intra-arterial Etherton 1989a) vs i.m. (present study and Dunshea et al., 1992a) , may also influence the acute responses to pGH, possibly due to differences in the kinetics of entry of exogenous hormone into the circulatory system.
Implications
Chronic treatment of pigs with porcine growth hormone has marked influences on growth rate, feed: gain, and protein and energy metabolism. This study examined some of the metabolic changes that occur upon acute administration of porcine growth hormone. Circulating levels of insulin and glucose were elevated, whereas urea was decreased; glucagon and nonesterified fatty acids were largely unaffected by treatment with growth hormone. The data suggest that young pigs have the capacity to respond to exogenous growth hormone treatment. Moreover, at a specific dose of growth hormone, based on body weight, the effective concentration is substantially higher for heavier pigs than for lighter pigs.
